Get startedLog in
    Picture of International Biotechnology Trust logo

    IBT — International Biotechnology Trust News Story

    0.000.00%
    gb flag iconLast trade - 00:00
    FinancialsBalancedSmall Cap
    All News

    Intnl. Biotechnology - Restatement of Net Asset Value(s)

    Picture of International Biotechnology Trust logoInternational Biotechnology Trust
    10/02/2026 12:02
    RNS Number : 4572S

Intl. Biotechnology Trust PLC

10 February 2026

 

10 February 2026

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 Restatement of Net Asset Value(s)

 

The Board of International Biotechnology Trust plc (the "Company") announces that, due to an administrative error relating to the non-accrual of the Company's most recent interim dividend, the Company's unaudited cum income net asset value ("NAV") per share has been restated for the following dates, as follows:

 


    DatePublished Cum Income NAV per ShareRevised Cum Income NAV per Share
    29/12/20251021.501005.87
    30/12/20251016.301000.69
    31/12/20251024.001008.35
    02/01/20261013.20997.59
    05/01/2026998.07982.44
    06/01/20261004.10988.51
    07/01/20261035.701020.10
    08/01/20261025.301009.67
    09/01/20261032.201016.53
    12/01/20261010.90995.29
    13/01/20261007.40991.72
    14/01/20261031.001015.36
    15/01/20261021.101005.51
    16/01/20261013.60997.96
    19/01/20261009.70994.04
    

 

As a result, the Company's service providers have implemented corrective measures and enhanced their procedures.

 

Enquiries:

Natalia de Sousa

Schroder Investment Management Limited

Tel: 020 7658 6000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
STRSFFFESEMSESE

    Recent news on International Biotechnology Trust

    See all news